Print
E-mail

education & research > BFS Research

BFS Peer-Reviewed Publication List

•  Grover S, Jacobs DS, Colby KA. Boston Ocular Surface Prosthesis for persistent epitheliopathy after treatment of conjunctival melanoma. Cornea. in press.

• Stason WB, Razavi M, Jacobs DS, Shepard DS, Suaya JA, Johns L, Rosenthal P. Clinical Benefits of the Boston Ocular Surface Prosthesis. Am J Ophthalmol. 2010; 54-61.

• Shepard DS, Razavi M, Stason WB, Jacobs DS, Suaya JA, Cohen M, Rosenthal P. Economic appraisal of the Boston Ocular Surface Prosthesis. Am J Ophthalmol. 2009; 860-868.

• Lim M, Jacobs DS, Rosenthal P, Carrasquillo KG. The Boston Ocular Surface Prosthesis as a novel drug delivery system for bevacizumab. Semin Ophthalmol. 2009; 149-155.

• Rosenthal P, Baran I, Jacobs DS. Corneal Pain without Stain: Is it Real? The Ocular Surface. 2009; 27-39.

• Lin SJ, Jacobs DS, Frankenthaler R and Rubin PAD. An ocular surface prosthesis as an innovative adjunct in patients with head and neck malignancy. Otolaryngol Head Neck Surg. 2008; 139:589-591.

• Jacobs DS. Update on scleral lenses. Curr Opin Ophthalmol 2008; 19:298-301.

• Gungor I, Schor K, Rosenthal P and Jacobs DS. The Boston Scleral Lens in the treatment of pediatric patients. J AAPOS 2008; 12:263-267.

• Takahide K, Parker PM, Wu M, Hwang WYK, Carpenter PA, Moravec C, Stehr B, Martin PJ, Rosenthal P, Forman SJ, Flowers MED. Use of fluid-ventilated, gas-permeable scleral lens for management of severe keratoconjunctivitis sicca secondary to chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13:1016-1021.

• Jacobs DS, Rosenthal P. Boston Scleral Lens prosthetic device for treatment of severe dry eye in chronic graft-versus-host disease. Cornea 2007; 26:1195-1199.

• Rosenthal P, Jacobs DS, Johns L. Fluid-ventilated gas permeable scleral lens: a new paradigm for the management of irregular corneal astigmatism and severe ocular surface disease. Contemporary Ophthalmology 2006; 5:1-7.

• Rosenthal P, Croteau A. Fluid-ventilated, gas-permeable scleral contact lens is an effective option for managing severe ocular surface disease and many corneal disorders that would otherwise require penetrating keratoplasty. Eye & Contact Lens 2005; 31:130-134.

• Rosenthal P, Cotter JM, Baum J. Treatment of persistent corneal epithelial defect with extended wear of a fluid-ventilated gas permeable scleral contact lens. Am J Ophthalmol 2000; 130:33-38.

• Rosenthal P, Cotter JM. The Boston Scleral Lens in the management of severe ocular surface disease. Ophthalmol Clin North Am 2003; 16:89-93.

• Romero-Rangel T, Stravrou P, Cotter J, Rosenthal P, Baltatzis S, Foster CS. Gas-permeable scleral contact lens therapy in ocular surface disease. Am J Ophthalmol 2000; 130:25-32.

• Cotter JM, Rosenthal P. Scleral contact lenses. J Am Optom Assoc 1998; 69:33-40.

• Rosenthal P, Cotter JM. Clinical performance of a spline-based apical vaulting keratoconus corneal contact lens design. CLAO J 1995; 21: 42-46.

• Schein OD, Rosenthal P, Ducharme C. A gas-permeable scleral contact lens for visual rehabilitation. Am J Ophthalmol 1990; 109:318-322. (NOTE: this publication was written by BFS Founder, Dr. Rosenthal, prior to the founding of BFS)